ArticlePolymers2026
Scalable Nanoemulsion Formation of Lipophilic Active Ingredients via Low-Energy Phase Inversion.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nanoemulsions are widely recognized as versatile delivery platforms capable of stably loading lipophilic active ingredients. Although low-energy phase inversion methods enable nanoemulsion formation under ambient and low-shear conditions, their scalability and applicability in practical formulation environments remain insufficiently validated. Here, we develop oil-in-water (O/W) nanoemulsions via a low-energy phase inversion process and systematically investigate their composition-dependent formation, scalability, and formulation stability. By precisely tuning the composition of a mixed nonionic surfactant system, monodisperse nanoemulsions with an average droplet size of ~110 nm and a polydispersity index (PDI ≤ 0.20) are reproducibly obtained under ambient, low-shear conditions. The optimized nanoemulsions maintain their nanoscale dispersion characteristics over 30 days of storage and exhibit consistent droplet size and distribution upon scale-up to 1 L. Furthermore, the nanoemulsions retain structural stability when incorporated into polymer-based formulations under various temperature conditions and repeated thermal cycling. These results demonstrate that low-energy phase inversion enables a scalable and formulation-compatible nanoemulsion platform, providing practical guidelines for industrial formulation and manufacturing of delivery systems for lipophilic active ingredients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.